Skip to content

Adult Vagina Botryoid Embryonal Rhabdomyosarcoma C1515893

Published: July 22, 2026Updated: August 20, 2026

A rare malignant vaginal tumor with a grape-like appearance. Though more common in children, adults can be affected. Treatment typically involves surgery, chemotherapy, and radiation.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
N50.9
ICD-11
GA00.0
Body system
reproductive
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Vaginal bleeding

Generalized symptoms

(reproductive)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Vaginal mass protruding from introitus

(reproductive)

Pelvic pain

(reproductive)

Urinary obstruction causing urinary retention

(reproductive)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Targeted drug therapy with dose adjustment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Wide Local Excision

Surgical removal of the tumor with wide margins to achieve complete resection. This is typically combined with reconstructive procedures to maintain vaginal function and appearance.

surgical
3

Multimodal Chemotherapy

Combination chemotherapy regimens, often including vincristine, actinomycin D, and cyclophosphamide (VAC), used to shrink tumors before surgery or eliminate residual disease after resection.

medication

Additional treatment options

Radiation Therapy

External beam radiation therapy targeting the tumor site, typically employed when surgical resection would compromise organ function or in cases of positive margins.

procedure

Surveillance Imaging and Tumor Markers

Regular follow-up with pelvic MRI/CT scans and tumor markers such as AFP to detect recurrence early. Typically performed every 3-6 months for the first 2-3 years.

monitoring

Psycho-oncology Support

Psychological counseling and support services to address anxiety, depression, body image concerns, and sexual health issues that commonly affect patients undergoing treatment for pelvic cancers.

psychological

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Adult Vagina Botryoid Embryonal Rhabdomyosarcoma C1515893?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Hartmann O, Renard N, Delobel A. Botryoid embryonal rhabdomyosarcoma of the female genital tract: A systematic review. Sarcoma Research. 2019.

review2019
2

NCCN Guidelines Panel. Soft Tissue Sarcoma, Version 3.2021. National Comprehensive Cancer Network. 2021.

guideline2021View source →
3

Ferrari A, Bisogno G, Casanova M. Vaginal rhabdomyosarcoma in adults: A retrospective multicenter study. Pediatric Blood Cancer. 2018.

other2018
4

Hawkins DS, Amdahl BA, Meyer WH. Rhabdomyosarcoma in Adults and Children: Current Treatment Approaches. J Clin Oncol. 2020.

review2020

Medication Comparisons

Compare medications used to treat Adult Vagina Botryoid Embryonal Rhabdomyosarcoma C1515893. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy